Skip to main content

Advertisement

SpringerLink
Log in

Treatment and Prevention of Recurrence of Multinodular Goiter: An Evidence-based Review of the Literature

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Reportedly, 10−15% of patients with goiters ultimately require operative intervention, and recurrences of multinodular goiter (MNG) account for up to 12% of all thyroid operations.

Methods

We performed an evidence-based review of articles published in the English language between January 1987 and October 2007 relevant to the subject.

Results

Medical treatment with T4 appears to be associated with a greater proportion of patients whose nodules decreased in size by more than 50% (22% vs. 10%; range = 14–39% vs. 0–20%). Recurrence rates of benign nodular goiter after total thyroidectomy were essentially nonexistent (range = 0–0.3%) compared with those after subtotal thyroidectomy (range = 2.5–42%) and more limited resections (range = 8–34%). There was no difference between total and less-than-total thyroidectomy with respect to temporary recurrent laryngeal nerve (RLN) injury (1–10% vs. 0.9–6%, respectively) or permanent RLN palsy (0–1.4%). There was, however, a significantly higher rate of transient hypocalcemia after total thyroidectomy than less extensive operations (9–35% vs. 0–18%, respectively). In relation to redo surgery, permanent hypoparathyroidism appeared to be far more common in the redo group (0–22% vs. 0–4%) Moreover; the redo group had more frequent RLN injury, both temporary (0–22% vs. 0.5–18%) and permanent (0–13% vs. 0–4%). About half the studies examined conclude that postoperative TSH suppression is effective in reducing recurrences, while the other half state that it is not.

Conclusion

The definitive management and prevention of recurrence of benign nodular goiter is primarily surgical. Total thyroidectomy essentially eliminates the risk of recurrence without an accompanying increased risk of permanent hypoparathyroidism or RLN injury. Therefore, total thyroidectomy should be considered the procedure of choice for benign multinodular goiter whenever possible, especially considering that reoperations for goiter are significantly more morbid than any initial operation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gaitan E, Nelson NC, Poole GV (1991) Endemic goiter and endemic thyroid disorders. World J Surg 5:205–215

    Article  Google Scholar 

  2. Muller PE, Jakoby R, Heinert G et al (2001) Surgery for recurrent goitre: its complications and their risk factors. Eur J Surg 167:816–821

    Article  PubMed  CAS  Google Scholar 

  3. Tunbridge WM, Evered DC, Hall R et al (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7:481–493

    Article  CAS  Google Scholar 

  4. Brander A, Viikinkoski P, Nickels J et al (1991) Thyroid gland: US screening in a random adult population. Radiology 181:683–687

    PubMed  CAS  Google Scholar 

  5. Mortensen JD, Woolner LB, Bennett WA (1955) Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 15:1270–1280

    Article  PubMed  CAS  Google Scholar 

  6. Matovinovic J (1983) Endemic goiter and cretinism at the dawn of the third millennium. Annu Rev Nutr 3:341–412

    Article  PubMed  CAS  Google Scholar 

  7. Torre G, Barreca A, Borgonovo G et al (2000) Goiter recurrence in patients submitted to thyroid-stimulating hormone suppression: possible role of insulin-like growth factors and insulin-like growth factor-binding proteins. Surgery 127:99–103

    Article  PubMed  CAS  Google Scholar 

  8. Kraimps JL, Marechaud R, Gineste D et al (1993) Analysis and prevention of recurrent goiter. Surg Gynecol Obstet 176:319–322

    PubMed  CAS  Google Scholar 

  9. Seiler CA, Glaser C, Wagner HE (1996) Thyroid gland surgery in an endemic region. World J Surg 20:593–596; discussion 596–597

    Article  PubMed  CAS  Google Scholar 

  10. Miccoli P, Antonelli A, Iacconi P et al (1993) Prospective, randomized, double-blind study about effectiveness of levothyroxine suppressive therapy in prevention of recurrence after operation: result at the third year of follow-up. Surgery 114:1097–1101; discussion 1101–1092

    PubMed  CAS  Google Scholar 

  11. Bifulco M, Cavallo P (2007) Thyroidology in the medieval medical school of Salerno. Thyroid 17:39–40

    Article  PubMed  Google Scholar 

  12. American Association of Clinical Endocrinologists (2004) Protocol for standardized production of clinical practice guidelines. Endocr Pract 10:353–361

    Google Scholar 

  13. Castro MR, Caraballo PJ, Morris JC (2002) Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab 87:4154–4159

    Article  PubMed  CAS  Google Scholar 

  14. Sdano MT, Falciglia M, Welge JA et al (2005) Efficacy of thyroid hormone suppression for benign thyroid nodules: meta-analysis of randomized trials. Otolaryngol Head Neck Surg 133:391–396

    Article  PubMed  Google Scholar 

  15. Koc M, Ersoz HO, Akpinar I et al (2002) Effect of low- and high-dose levothyroxine on thyroid nodule volume: a crossover placebo-controlled trial. Clin Endocrinol (Oxf) 57:621–628

    Article  CAS  Google Scholar 

  16. Wemeau JL, Caron P, Schvartz C et al (2002) Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. J Clin Endocrinol Metab 87:4928–4934

    Article  PubMed  CAS  Google Scholar 

  17. Pappalardo G, Guadalaxara A, Frattaroli FM et al (1998) Total compared with subtotal thyroidectomy in benign nodular disease: personal series and review of published reports. Eur J Surg 164:501–506

    Article  PubMed  CAS  Google Scholar 

  18. Bellantone R, Lombardi CP, Boscherini M et al (2004) Predictive factors for recurrence after thyroid lobectomy for unilateral non-toxic goiter in an endemic area: results of a multivariate analysis. Surgery 136:1247–1251

    Article  PubMed  Google Scholar 

  19. Gibelin H, Sierra M, Mothes D et al (2004) Risk factors for recurrent nodular goiter after thyroidectomy for benign disease: case-control study of 244 patients. World J Surg 28:1079–1082

    Article  PubMed  Google Scholar 

  20. Colak T, Akca T, Kanik A et al (2004) Total versus subtotal thyroidectomy for the management of benign multinodular goiter in an endemic region. ANZ J Surg 74:974–978

    Article  PubMed  Google Scholar 

  21. Erbil Y, Barbaros U, Salmaslioglu A et al (2006) The advantage of near-total thyroidectomy to avoid postoperative hypoparathyroidism in benign multinodular goiter. Langenbecks Arch Surg 391:567–573

    Article  PubMed  Google Scholar 

  22. Friguglietti CU, Lin CS, Kulcsar MA (2003) Total thyroidectomy for benign thyroid disease. Laryngoscope 113:1820–1826

    Article  PubMed  Google Scholar 

  23. Liu Q, Djuricin G, Prinz RA (1998) Total thyroidectomy for benign thyroid disease. Surgery 123:2–7

    PubMed  CAS  Google Scholar 

  24. Marchesi M, Biffoni M, Faloci C et al (2002) High rate of recurrence after lobectomy for solitary thyroid nodule. Eur J Surg 168:397–400

    Article  PubMed  Google Scholar 

  25. Snook KL, Stalberg PL, Sidhu SB et al (2007) Recurrence after total thyroidectomy for benign multinodular goiter. World J Surg 31:593–598; discussion 599–600

    Article  PubMed  Google Scholar 

  26. Sosa JA, Bowman HM, Tielsch JM et al (1998) The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 228:320–330

    Article  PubMed  CAS  Google Scholar 

  27. Thomusch O, Machens A, Sekulla C et al (2000) Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: prospective multicenter study in Germany. World J Surg 24:1335–1341

    Article  PubMed  CAS  Google Scholar 

  28. Feldkamp J, Seppel T, Becker A et al (1997) Iodide or L-thyroxine to prevent recurrent goiter in an iodine-deficient area: prospective sonographic study. World J Surg 21:10–14

    Article  PubMed  CAS  Google Scholar 

  29. Hegedus L, Nygaard B, Hansen JM (1999) Is routine thyroxine treatment to hinder postoperative recurrence of nontoxic goiter justified? J Clin Endocrinol Metab 84:756–760

    Article  PubMed  CAS  Google Scholar 

  30. Banchuin C, Panpimarnmas S (1997) Effect of post-operative thyroid hormone therapy on the recurrence of benign thyroid nodules. A study in Thai patients. J Med Assoc Thai 80:715–719

    PubMed  CAS  Google Scholar 

  31. Geerdsen JP, Frolund L (1984) Recurrence of nontoxic goitre with and without postoperative thyroxine medication. Clin Endocrinol (Oxf) 21:529–533

    Article  CAS  Google Scholar 

  32. Berghout A, Wiersinga WM, Drexhage HA et al (1989) The long-term outcome of thyroidectomy for sporadic non-toxic goitre. Clin Endocrinol (Oxf) 31:193–199

    Article  CAS  Google Scholar 

  33. Bistrup C, Nielsen JD, Gregersen G et al (1994) Preventive effect of levothyroxine in patients operated for non-toxic goitre: a randomized trial of one hundred patients with nine years follow-up. Clin Endocrinol (Oxf) 40:323–327

    Article  CAS  Google Scholar 

  34. Persson CP, Johansson H, Westermark K et al (1982) Nodular goiter—is thyroxine medication of any value? World J Surg 6:391–396

    Article  PubMed  CAS  Google Scholar 

  35. Anderson PE, Hurley PR, Rosswick P (1990) Conservative treatment and long term prophylactic thyroxine in the prevention of recurrence of multinodular goiter. Surg Gynecol Obstet 171:309–314

    PubMed  CAS  Google Scholar 

  36. Ibis E, Erbay G, Aras G et al (1991) Postoperative goitre recurrence rate in Turkey. Acta Endocrinol (Copenh) 125:33–37

    CAS  Google Scholar 

  37. Subbiah S, Collins BJ, Schneider AB (2007) Factors related to the recurrence of thyroid nodules after surgery for benign radiation-related nodules. Thyroid 17:41–47

    Article  PubMed  Google Scholar 

  38. Wadstrom C, Zedenius J, Guinea A et al (1999) Multinodular goitre presenting as a clinical single nodule: how effective is hemithyroidectomy? Aust N Z J Surg 69:34–36

    Article  PubMed  CAS  Google Scholar 

  39. Roher HD, Goretzki PE (1987) Management of goiter and thyroid nodules in an area of endemic goiter. Surg Clin North Am 67:233–249

    PubMed  CAS  Google Scholar 

  40. Bennedbaek FN, Hegedus L (2000) Management of the solitary thyroid nodule: results of a North American survey. J Clin Endocrinol Metab 85:2493–2498

    Article  PubMed  CAS  Google Scholar 

  41. Bennedbaek FN, Perrild H, Hegedus L (1999) Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey. Clin Endocrinol (Oxf) 50:357–363

    Article  CAS  Google Scholar 

  42. Astwood EB, Cassidy CE, Aurbach GD (1960) Treatment of goiter and thyroid nodules with thyroid. JAMA 174:459–464

    PubMed  CAS  Google Scholar 

  43. Schneeberg NG, Stahl TJ, Maldia G et al (1962) Regression of goiter by whole thyroid or triiodothyronine. Metabolism 11:1054–1060

    PubMed  CAS  Google Scholar 

  44. Hansen JM, Kampmann J, Madsen SN et al (1979) L-thyroxine treatment of diffuse non-toxic goitre evaluated by ultrasonic determination of thyroid volume. Clin Endocrinol (Oxf) 10:1–6

    Article  CAS  Google Scholar 

  45. Perrild H, Hansen JM, Hegedus L et al (1982) Triiodothyronine and thyroxine treatment of diffuse non-toxic goitre evaluated by ultrasonic scanning. Acta Endocrinol (Copenh) 100:382–387

    CAS  Google Scholar 

  46. La Rosa GL, Lupo L, Giuffrida D et al (1995) Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med 122:1–8

    PubMed  CAS  Google Scholar 

  47. Gharib H, James EM, Charboneau JW et al (1987) Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study. N Engl J Med 317:70–75

    Article  PubMed  CAS  Google Scholar 

  48. Reverter JL, Lucas A, Salinas I et al (1992) Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol (Oxf) 36:25–28

    Article  CAS  Google Scholar 

  49. Burman KD (1990) Is long-term levothyroxine therapy safe?. Arch Intern Med 150:2010–2013

    Article  PubMed  CAS  Google Scholar 

  50. Faber J, Galloe AM (1994) Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol 130:350–356

    PubMed  CAS  Google Scholar 

  51. Sawin CT, Geller A, Wolf PA et al (1994) Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249–1252

    Article  PubMed  CAS  Google Scholar 

  52. Biondi B, Fazio S, Palmieri EA et al (1999) [Effects of chronic subclinical hyperthyroidism from levothyroxine on cardiac morphology and function.]. Cardiologia 44:443–449

    PubMed  CAS  Google Scholar 

  53. Bauer DC, Ettinger B, Nevitt MC et al (2001) Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 134:561–568

    PubMed  CAS  Google Scholar 

  54. Harrer P, Broecker M, Zint A et al (1998) Thyroid nodules in recurrent multinodular goiters are predominantly polyclonal. J Endocrinol Invest 21:380–385

    PubMed  CAS  Google Scholar 

  55. Harrer P, Brocker M, Zint A et al (1998) The clonality of nodules in recurrent goiters at second surgery. Langenbecks Arch Surg 383:453–455

    Article  PubMed  CAS  Google Scholar 

  56. Goretzki P, Roeher HD, Horeyseck G (1981) Prophylaxis of recurrent goiter by high-dose L-thyroxine. World J Surg 5:855–857

    Article  PubMed  CAS  Google Scholar 

  57. Hegedus L, Hansen JM, Veiergang D et al (1987) Does prophylactic thyroxine treatment after operation for non-toxic goitre influence thyroid size? Br Med J (Clin Res Ed) 294:801–803

    Article  CAS  Google Scholar 

  58. Carella C, Mazziotti G, Rotondi M et al (2002) Iodized salt improves the effectiveness of L-thyroxine therapy after surgery for nontoxic goitre: a prospective and randomized study. Clin Endocrinol (Oxf) 57:507–513

    Article  CAS  Google Scholar 

  59. Guberti A, Sianesi M, Del Rio P et al (2002) Thyroid function and goiter recurrence after thyroid lobectomy in elderly subjects. J Endocrinol Invest 25:71–72

    PubMed  CAS  Google Scholar 

  60. Erbil Y, Bozbora A, Yanik BT et al (2007) Predictive factors for recurrent non-toxic goitre in an endemic region. J Laryngol Otol 121:231–236

    Article  PubMed  CAS  Google Scholar 

  61. Lange MJ, Piercy JE (1957) Recurrent goitre. Lancet 272:177–181

    PubMed  CAS  Google Scholar 

  62. Makeieff M, Rubinstein P, Youssef B et al (1998) [Repeat surgery for thyroid nodules (excluding cancer and hyperthyroidism).]. Ann Chir 52:970–977

    PubMed  CAS  Google Scholar 

  63. Farrag TY, Samlan RA, Lin FR et al (2006) The utility of evaluating true vocal fold motion before thyroid surgery. Laryngoscope 116:235–238

    Article  PubMed  Google Scholar 

  64. Ardito G, Revelli L, D’Alatri L et al (2004) Revisited anatomy of the recurrent laryngeal nerves. Am J Surg 187:249–253

    Article  PubMed  Google Scholar 

  65. Steinberg JL, Khane GJ, Fernandes CM et al (1986) Anatomy of the recurrent laryngeal nerve: a redescription. J Laryngol Otol 100:919–927

    Article  PubMed  CAS  Google Scholar 

  66. Dralle H, Sekulla C, Haerting J et al (2004) Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery 136:1310–1322

    Article  PubMed  Google Scholar 

  67. Cohen-Kerem R, Schachter P, Sheinfeld M et al (2000) Multinodular goiter: the surgical procedure of choice. Otolaryngol Head Neck Surg 122:848–850

    Article  PubMed  CAS  Google Scholar 

  68. Piraneo S, Vitri P, Galimberti A et al (1994) Recurrence of goitre after operation in euthyroid patients. Eur J Surg 160:351–356

    PubMed  CAS  Google Scholar 

  69. Reeve TS, Delbridge L, Cohen A et al (1987) Total thyroidectomy. The preferred option for multinodular goiter. Ann Surg 206:782–786

    Article  PubMed  CAS  Google Scholar 

  70. Rios A, Rodriguez JM, Canteras M et al (2005) Surgical management of multinodular goiter with compression symptoms. Arch Surg 140:49–53

    Article  PubMed  Google Scholar 

  71. Rios A, Rodriguez JM, Balsalobre MD et al (2005) Results of surgery for toxic multinodular goiter. Surg Today 35:901–906

    Article  PubMed  Google Scholar 

  72. Rojdmark J, Jarhult J (1995) High long term recurrence rate after subtotal thyroidectomy for nodular goitre. Eur J Surg 161:725–727

    PubMed  CAS  Google Scholar 

  73. Delbridge L, Guinea AI, Reeve TS (1999) Total thyroidectomy for bilateral benign multinodular goiter: effect of changing practice. Arch Surg 134:1389–1393

    Article  PubMed  CAS  Google Scholar 

  74. Menegaux F, Turpin G, Dahman M et al (1999) Secondary thyroidectomy in patients with prior thyroid surgery for benign disease: a study of 203 cases. Surgery 126:479–483

    PubMed  CAS  Google Scholar 

  75. Lang BH, Lo CY (2005) Total thyroidectomy for multinodular goiter in the elderly. Am J Surg 190:418–423

    Article  PubMed  Google Scholar 

  76. Zambudio AR, Rodriguez J, Riquelme J et al (2004) Prospective study of postoperative complications after total thyroidectomy for multinodular goiters by surgeons with experience in endocrine surgery. Ann Surg 240:18–25

    Article  PubMed  Google Scholar 

  77. Serpell JW, Phan D (2007) Safety of total thyroidectomy. ANZ J Surg 77:15–19

    Article  PubMed  Google Scholar 

  78. Berglund J, Bondesson L, Christensen SB et al (1990) Indications for thyroxine therapy after surgery for nontoxic benign goitre. Acta Chir Scand 156:433–438

    PubMed  CAS  Google Scholar 

  79. Karanikolic A, Pesic M, Djordevic N et al (2007) Optimal surgical treatment for bilateral multinodular goitre. Surg Prac 11:12–16

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrine Surgery, University of California, San Francisco, CA, 94143, USA

    Jacob Moalem, Insoo Suh & Quan-Yang Duh

  2. Surgical Service, Veteran Affairs Medical Center, 4150 Clement Street, San Francisco, CA, 94121, USA

    Quan-Yang Duh

Authors
  1. Jacob Moalem
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Insoo Suh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Quan-Yang Duh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Quan-Yang Duh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moalem, J., Suh, I. & Duh, QY. Treatment and Prevention of Recurrence of Multinodular Goiter: An Evidence-based Review of the Literature. World J Surg 32, 1301–1312 (2008). https://doi.org/10.1007/s00268-008-9477-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-008-9477-0

Keywords

Search

Navigation